How Roche Is Shaping China’s Connected Digital Health Future

Share this article
Share this article
Prioritise Us on Google
Francis Kee, Head of Roche Information Solutions (RIS) China. Credit: Roche
Francis Kee explores how Roche is bringing digital health technology, diagnostics and clinical care together to streamline patient journeys across China

For Francis Kee, Head of Roche Information Solutions (RIS) China, the motivation continuing to drive his work after more than two decades in the healthcare industry is clear: “seeing firsthand how our technology and innovations genuinely improve people’s lives.”

With more than 15 years at Roche and holding executive roles across the healthcare sector, Francis has witnessed firsthand how technological advances have reshaped healthcare. 

Throughout his career, witnessing the pace of technological change and its impact on patients has deepened Francis’ passion for digital health, which he sees as a powerful driver of healthcare transformation and better patient care.

From disconnected to unified

Evolving patient journeys in China from a series of disconnected, individual stages to a single unified process is a defining mission for Francis and his team.

By bringing Roche’s pharmaceutical, diagnostics and digital health capabilities together under its One Roche approach, the company aims to connect traditionally separate stages of care.

The result, Francis explains, is an “end-to-end digital solution across the entire disease management process.”

In practice, this means integrating digital tools across the patient journey, from early screening and accurate diagnosis to personalised treatment plans and long-term follow-up care. 

“By embedding integrated digital health solutions into hospitals and laboratory workflows,” Francis explains, “we are contributing to the transformation from fragmented care to cohesive data-driven collaborations.”

The One Roche end-to-end, integrated digital health solution will, in turn, “elevate the standard of care across the whole patient journey.”

Roche Diagnostics China Head Office in Shanghai. Credit: Roche

Closing the care gap through connected health

China’s vast geography presents another challenge to creating a more connected patient journey: disparities in access to healthcare between rural communities, smaller cities and major urban centres remain stark.

Many patients from rural areas and even smaller urban areas travel to hospitals in cities such as Shanghai and Beijing to access specialist tertiary care that may not be available locally.

Francis believes addressing this imbalance requires a network of hospitals with different levels of capability, tailored to local needs.

While larger tertiary hospitals can deploy more sophisticated digital solutions, primary care providers can use simpler tools to identify patients who may require specialist attention.

Mobile health applications can also extend access to care beyond the hospital, but they are not a viable option for everyone. Patients without access to a mobile phone or the necessary applications may require alternative approaches.

“We also need solutions that can be implemented on-site,” Francis explains.

The real world impact on patients’ lives is what inspires my passion for this work

Francis Kee, Head of Roche Information Solutions (RIS) China

At one Shanghai hospital Francis cites as an example, a registration booth allows patients to sign up for follow-up communications and indicate whether they would prefer to be contacted by telephone, SMS or WeChat.

Offering a choice helps ensure that communication is tailored to patients’ circumstances rather than relying on a single approach.

Effective outreach is equally important to the success of screening programmes. Raising awareness is only part of the challenge; healthcare teams must also ensure that people attend screenings and receive appropriate follow-up care.

“In some cases,” Francis says, “doctors and medical teams have screening targets but struggle to reach the intended patients. They may need to conduct door-to-door outreach, while also helping patients register digitally when they visit a healthcare centre.”

For Francis, combining digital health solutions with more traditional forms of outreach will remain essential over the next three to five years.

By adapting approaches to local needs and patients’ circumstances, healthcare providers can help more people access appropriate care and support a more connected patient journey.

Roche Headquarters in Basel, Switzerland. Credit: Roche

The next generation of digital health

Delivering more connected patient journeys also depends on the technologies and infrastructure underpinning healthcare. As digital health evolves, Francis identifies four key trends that he believes will shape its next phase of “intelligent value creation.”

These span the policy frameworks governing adoption, the data infrastructure supporting interoperability, the integration of AI into clinical workflows and the use of health data to generate actionable clinical insights.

  1. Policy and governance: Moving beyond basic digitalisation towards the systematic advancement of intelligent healthcare.
     
  2. Data infrastructure: Shifting from implementing IT systems to ensuring data is usable and interoperable across different platforms.
     
  3. AI: Embedding AI more deeply into everyday clinical workflows, rather than limiting its role to isolated applications.
     
  4. Clinical insights: Turning health data into actionable insights that can inform research, quality improvement and clinical decision-making.

Francis believes these combined trends will produce a “unified and scalable technology stack, consolidating infrastructure, data and analytics onto a platform so that data health solutions across laboratory and clinical care can share data seamlessly.”

Healthcare’s digital transformation is not a journey any single company can walk alone

Francis Kee, Head of Roche Information Solutions (RIS) China

Alongside this infrastructure, specialised clinical algorithms and medical intelligence platforms will be important in translating data into “actionable decision support at the point of care”. The aim is not simply to collect more information, but to make it useful to clinicians when and where decisions are made.

Localised AI and high-performance computing will also play a critical role.

Francis notes that many hospitals still lack the computing capacity needed to embed these technologies into their operations.

However, embedding local AI and large language models directly into those hospitals with high-throughput workflows will be critical for processing medical data rapidly, securely and reliably.

Roche’s digital health vision connects infrastructure, data and analytics. Credit: Getty Images

Advancing Liver Cancer Screening and Care Pathways in China

With China accounting for a substantial share of global liver cancer diagnoses, clinical priorities have increasingly centered on early intervention and care continuum optimisation – areas where innovative digital health technologies offer practical pathways for disease management transformation. 

Raising public awareness, strengthening screening for high-risk populations, and shifting detection from intermediate or advanced stages to early screening are urgent priorities for healthcare providers and public health initiatives. 

To support this goal, integrated approaches focus on connecting screening, institutional diagnosis, and long-term out-of-hospital management into a cohesive pathway.

The navify Liver Disease Pathway (LDP), developed by RIS China for the China market, represents this approach to digital health integration.

Key Stats: Liver Cancer Rates in China
  • Around 50% of global liver cancer diagnoses occur in China.
  • 80% of liver cancer cases in China are diagnosed at an advanced stage.
  • 12%: the five-year survival rate for liver cancer patients in China.
  • Below 30% to above 85%: early diagnosis rates achieved in high-risk pilot screening programs in Shanghai and Shenzhen, compared to the national average below 30%.

Facilitating tailored follow-up strategies, the digital health solution connects inpatient and out-of-hospital care, while integrating digital technologies into clinical workflows, simplifying complex assessments, and ultimately lightening the patient management workload and significantly improving patient outcomes. 

The progress made gives “significantly more patients a chance at curative treatments and long-term survival,” says Francis.

In pilot screening programs across Shanghai and Shenzhen, coordinated pathways have helped lift early diagnosis rates in participating populations from baseline levels below 30% to over 85%, significantly broadening the window for curative intervention.

The benefits of navify LDP extend beyond clinical accuracy. By integrating community health centres and tertiary hospitals into an automated screening, diagnosis and patient management network, the solution streamlines multi-departmental consultations, automates patient follow-up and boosts clinical team efficiency.

Ultimately, RIS China’s goal with navify LDP is to “transform fragmented care into proactive data-driven disease management that extends lives across China.”

Digital solutions can help connect patients across China’s diverse healthcare landscape. Credit: Roche

Partnerships for a patient-first future

Looking ahead, Francis sees the next five years bringing a shift from basic digitisation to “intelligent value creation”, as China’s healthcare system makes greater use of digital technologies to improve patient care.

Health data will move beyond its traditional role as a record of clinical activity to generate “active clinical insights”, while AI becomes more deeply embedded in everyday hospital workflows.

At the same time, connected regional networks will help coordinate care across the entire patient journey.

For Roche, realising this vision means “building up a sustainable digital health ecosystem together with local partners”.

By combining shared technology infrastructure and specialised medical intelligence with the expertise of local health authorities, medical institutions and technology innovators, Francis says, the company aims to accelerate digital transformation and deliver more personalised care to patients across China.

Roche’s digital health vision connects infrastructure, data and analytics. Credit: Roche

Achieving this ambition, however, will require collaboration across the healthcare and technology sectors.

As Francis puts it, “healthcare’s digital transformation is not a journey any single company can walk alone.”

RIS China is therefore committed to co-creating China’s digital health ecosystem with partners ranging from technology leaders such as Huawei to clinicians, laboratory directors and patients themselves.

Bringing these different perspectives together can help overcome fragmented systems and make better use of health data.

Ultimately, Francis believes that collaboration will be key to unlocking the full potential of digital health.

By breaking down silos and combining expertise across the ecosystem, he says RIS China and its partner network can “shape the future of healthcare together for every patient in China.”

Executives